Hard to Treat Diseases (HTDS) Discusses Divestiture of Collagenna (AGIJ) PR Newswire SHENZEN, China, July 13 SHENZEN, China, July 13 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS;...
Hard to Treat Diseases, Inc. (HTDS) Signs with New Partner in Ethiopia PR Newswire SHENZHEN, China, July 6 SHENZHEN, China, July 6 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS;...
Hard to Treat Diseases, Inc. (HTDS) Received the First Order for Pakistani Market PR Newswire SHENZEN, China, June 10 SHENZEN, China, June 10 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc...
Hard To Treat Diseases (HTDS.PK) Scientists report results that are encouraging for the future of Multiple Sclerosis Treatment PR Newswire BELGRADE, Serbia, June 3 BELGRADE, Serbia, June 3...
Hard to Treat Diseases (HTDS) Collagenna Skin Care Products Exhibits at Canada's Largest Professional Esthetics and Spa Show PR Newswire OTTAWA, June 2 OTTAWA, June 2 /PRNewswire-FirstCall/...
Hard to Treat Diseases, Inc. (HTDS) Commenced Clinical Trials in Vietnam PR Newswire SHENZEN, China, June 1 SHENZEN, China, June 1 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS;...
Hard to Treat Diseases, Inc. (HTDS) CEO Audio Address Business Expectations for 2010 PR Newswire SHENZEN, China, May 24 SHENZEN, China, May 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases...
Hard to Treat Diseases (HTDS) Collagenna Skin Care Products Signs Distribution Agreement with Malaysian Partner PR Newswire OTTAWA, May 21 OTTAWA, May 21 /PRNewswire-FirstCall/ - Hard to Treat...
Hard to Treat Diseases (HTDS) Collagenna Skin Care Products Reaches Distribution Agreement for Texas PR Newswire OTTAWA, May 20 OTTAWA, May 20 /PRNewswire-FirstCall/ - Hard to Treat Diseases...
Hard to Treat Diseases (HTDS) Begins Subscription to Pink Sheets PR Newswire SHENZEN, China, May 19 SHENZEN, China, May 19 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS;...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 83000 | 1.0E-6 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1369811 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 915229 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 702737 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 2.0E-6 | 1.0E-6 | 1126521 | 1.0E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 701799 | 1.02E-6 | CS |
260 | -9.9E-5 | -99 | 0.0001 | 0.0008 | 1.0E-6 | 5243847 | 0.00027396 | CS |
Symbole | Prix | Vol. |
---|---|---|
HMBLHUMBL Inc (PK) | US$ 0,0009 (0,00%) | 359,72M |
GRLFGreen Leaf Innovations Inc (PK) | US$ 0,00015 (50,00%) | 194,9M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,00375 (-1,32%) | 188,36M |
TSOITherapeutic Solutions International Inc (PK) | US$ 0,0002 (-33,33%) | 168,26M |
PHILPHI Group Inc (PK) | US$ 0,00025 (-16,67%) | 129,87M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales